Published in Cancer Chemother Pharmacol on January 01, 1992
Current treatment modalities for hepatocellular carcinoma. Ann Surg (1994) 1.59
CT volume measurement for prognostic evaluation of unresectable hepatocellular carcinoma after TACE. World J Gastroenterol (2010) 0.90
New development of transarterial immunoembolization (TIE) for therapy of hepatocellular carcinoma with intrahepatic metastases. Cancer Chemother Pharmacol (1994) 0.77
Evaluation of the therapeutic effect of TAE on primary liver cancer. Cancer Chemother Pharmacol (1994) 0.75
Transection of the oesophagus for bleeding oesophageal varices. Br J Surg (1973) 26.26
Surgical anatomy and anatomical surgery of the liver. World J Surg (1982) 3.96
Hepatic artery embolization in 120 patients with unresectable hepatoma. Radiology (1983) 3.67
Ultrasonically guided subsegmentectomy. Surg Gynecol Obstet (1985) 3.42
The general rules for the clinical and pathological study of primary liver cancer. Liver Cancer Study Group of Japan. Jpn J Surg (1989) 3.30
Major hepatic resection for neoplasia: personal experience in 108 patients. Ann Surg (1978) 2.80
Personal experience with 411 hepatic resections. Ann Surg (1988) 2.46
Major hepatic resection under total vascular exclusion. Ann Surg (1989) 2.29
Limited hepatic resection effective for selected cirrhotic patients with primary liver cancer. Ann Surg (1984) 2.07
Hepatic arterial embolization in patients with unresectable hepatocellular carcinoma--a randomized controlled trial. Gastroenterology (1988) 1.91
Allele loss on chromosome 16 associated with progression of human hepatocellular carcinoma. Proc Natl Acad Sci U S A (1990) 1.90
Hepatic resection for hepatocellular carcinoma. Surgery (1990) 1.64
Prognostic factors after hepatectomy for hepatocellular carcinomas. A univariate and multivariate analysis. Cancer (1990) 1.61
Estimation of the functional reserve of human liver. Ann Surg (1974) 1.49
Transcatheter occlusion of abdominal tumors. Radiology (1976) 1.41
Primary malignant tumors of the liver. Cancer (1971) 1.39
Prognosis of primary hepatocellular carcinoma. Hepatology (1984) 1.37
A multiple regression equation for prediction of posthepatectomy liver failure. Ann Surg (1984) 1.30
Transcatheter chemo-embolization effective for treating hepatocellular carcinoma. A histopathologic study. Cancer (1984) 1.20
Segmental and subsegmental resections of the cirrhotic liver under hepatic inflow and outflow occlusion. Br J Surg (1985) 1.20
Improved early results of elective hepatic resection for liver tumors. One hundred consecutive hepatectomies in cirrhotic and noncirrhotic patients. Arch Surg (1989) 1.18
Treatment of hepatocellular carcinoma by transcatheter arterial embolization combined with intraarterial infusion of a mixture of cisplatin and ethiodized oil. Gastroenterology (1989) 1.17
Primary liver cancer in Japan. Sixth report. The Liver Cancer Study Group of Japan. Cancer (1987) 1.15
Chemotherapy studies in primary liver cancer: a prospective randomized clinical trial. Cancer (1978) 1.13
Adriamycin treatment for hepatocellular carcinoma. Experience with 109 patients. Cancer (1985) 1.12
Liver transplantation for malignant tumors. Gastroenterol Clin North Am (1988) 1.09
An appraisal of transcatheter arterial embolization combined with transcatheter arterial infusion of chemotherapeutic agent for hepatic malignancies. World J Surg (1982) 1.05
Prognostic factors in patients with hepatocellular carcinoma. Attempts for the selection of patients with prolonged survival. Cancer (1987) 0.98
Iodized oil in the portal vein after arterial embolization. Radiology (1988) 0.97
Hepatic resection in 125 patients. Arch Surg (1984) 0.95
Medical treatment of hepatocellular carcinoma. Gastroenterol Clin North Am (1987) 0.93
Hepatocellular carcinoma: combined hepatic, arterial, and portal venous embolization. Radiology (1986) 0.88
Flow cytometric DNA analysis of hepatocellular carcinoma. Cancer (1991) 0.82
Significance of transcatheter chemoembolization combined with surgical resection for hepatocellular carcinomas. Cancer Chemother Pharmacol (1989) 0.82
Surgical management of hepatocellular carcinoma. Gastroenterol Clin North Am (1987) 0.81
Postoperative prognosis as related to blood ketone body ratios in hepatectomized patients. Eur Surg Res (1983) 0.81
Liver transplantation for malignant tumours. Baillieres Clin Gastroenterol (1989) 0.79
Arterial infusion chemotherapy of hepatoma. Surg Gynecol Obstet (1974) 0.79
Malignant tumors of the liver. Surg Clin North Am (1986) 0.77
Determination of the extent of feasible hepatic resection from hepatic blood flow. World J Surg (1986) 0.75
Structure, sequence and expression of the hepatitis delta (delta) viral genome. Nature (1986) 7.38
p53AIP1, a potential mediator of p53-dependent apoptosis, and its regulation by Ser-46-phosphorylated p53. Cell (2000) 5.64
Somatic mutations of the APC gene in colorectal tumors: mutation cluster region in the APC gene. Hum Mol Genet (1992) 5.14
Activation of calcium and phospholipid-dependent protein kinase by diacylglycerol, its possible relation to phosphatidylinositol turnover. J Biol Chem (1980) 5.08
Effects of matrix metalloproteinase-9 gene knock-out on the proteolysis of blood-brain barrier and white matter components after cerebral ischemia. J Neurosci (2001) 4.99
A glucose-responsive transcription factor that regulates carbohydrate metabolism in the liver. Proc Natl Acad Sci U S A (2001) 4.73
Advanced glycation end-products: a review. Diabetologia (2001) 4.59
Comparison of MB-Check, BACTEC, and egg-based media for recovery of mycobacteria. J Clin Microbiol (1992) 4.55
Germ-line mutations of the APC gene in 53 familial adenomatous polyposis patients. Proc Natl Acad Sci U S A (1992) 4.13
Calcium-dependent activation of a multifunctional protein kinase by membrane phospholipids. J Biol Chem (1979) 4.12
Plasma (1-->3)-beta-D-glucan measurement in diagnosis of invasive deep mycosis and fungal febrile episodes. Lancet (1995) 3.64
An improved method for isolation of mouse pancreatic islets. Transplantation (1985) 3.52
Nonadipose tissue production of leptin: leptin as a novel placenta-derived hormone in humans. Nat Med (1997) 3.35
Germline mutation of MSH6 as the cause of hereditary nonpolyposis colorectal cancer. Nat Genet (1997) 3.34
Molecular nature of colon tumors in hereditary nonpolyposis colon cancer, familial polyposis, and sporadic colon cancer. Gastroenterology (1996) 3.30
Identification of a novel phosphorylation site on histone H3 coupled with mitotic chromosome condensation. J Biol Chem (1999) 2.99
A single antigenomic open reading frame of the hepatitis delta virus encodes the epitope(s) of both hepatitis delta antigen polypeptides p24 delta and p27 delta. J Virol (1988) 2.99
Discovery of cyanovirin-N, a novel human immunodeficiency virus-inactivating protein that binds viral surface envelope glycoprotein gp120: potential applications to microbicide development. Antimicrob Agents Chemother (1997) 2.98
Unsaturated diacylglycerol as a possible messenger for the activation of calcium-activated, phospholipid-dependent protein kinase system. Biochem Biophys Res Commun (1979) 2.96
Cadherin dysfunction in a human cancer cell line: possible involvement of loss of alpha-catenin expression in reduced cell-cell adhesiveness. Cancer Res (1992) 2.89
Climbing fibre induced depression of both mossy fibre responsiveness and glutamate sensitivity of cerebellar Purkinje cells. J Physiol (1982) 2.80
International Conference for the Development of a Consensus on the Management and Prevention of Severe Candidal Infections. Clin Infect Dis (1997) 2.78
Circadian clock-protein expression in cyanobacteria: rhythms and phase setting. EMBO J (2000) 2.75
Gender difference in delays to diagnosis and health care seeking behaviour in a rural area of Nepal. Int J Tuberc Lung Dis (2001) 2.75
Gallbladder torsion: case report and review of 245 cases reported in the Japanese literature. J Hepatobiliary Pancreat Surg (1999) 2.68
Irradiation synchronized with respiration gate. Int J Radiat Oncol Biol Phys (1989) 2.63
A human gene responsible for Zellweger syndrome that affects peroxisome assembly. Science (1992) 2.63
Actinin-4, a novel actin-bundling protein associated with cell motility and cancer invasion. J Cell Biol (1998) 2.62
Benefit of IVIG for long-standing ataxic sensory neuronopathy with Sjögren's syndrome. IV immunoglobulin. Neurology (2003) 2.37
B cell subpopulations separated by CD27 and crucial collaboration of CD27+ B cells and helper T cells in immunoglobulin production. Eur J Immunol (1997) 2.29
Isolation and Characterization of an Enterobacter cloacae Strain That Reduces Hexavalent Chromium under Anaerobic Conditions. Appl Environ Microbiol (1989) 2.23
Higher frequency of Smad4 gene mutation in human colorectal cancer with distant metastasis. Oncogene (1999) 2.22
Growth and spread of hepatocellular carcinoma. A review of 240 consecutive autopsy cases. Cancer (1990) 2.22
Overexpression of cyclooxygenase-2 in carcinoma of the pancreas. Clin Cancer Res (1999) 2.20
Inhibitory action of chlorpromazine, dibucaine, and other phospholipid-interacting drugs on calcium-activated, phospholipid-dependent protein kinase. J Biol Chem (1980) 2.15
Reproducible high yield of rat islets by stationary in vitro digestion following pancreatic ductal or portal venous collagenase injection. Transplantation (1987) 2.14
Cloning, characterization and nucleotide sequences of two cDNAs encoding human pancreatic trypsinogens. Gene (1986) 2.14
Adrenal hemorrhage in the newborn with evidence of bleeding in utero. J Urol (1989) 2.05
Phosphorylation of vimentin by Rho-associated kinase at a unique amino-terminal site that is specifically phosphorylated during cytokinesis. J Biol Chem (1998) 2.04
Predictive factors for malignancy in intraductal papillary-mucinous tumours of the pancreas. Br J Surg (2003) 2.04
Increased expression of COX-2 in nontumor liver tissue is associated with shorter disease-free survival in patients with hepatocellular carcinoma. Clin Cancer Res (1999) 2.03
Quasiperiodicity and chaos in cardiac fibrillation. J Clin Invest (1997) 1.99
Safety of hemihepatic vascular occlusion during resection of the liver. Surg Gynecol Obstet (1987) 1.98
Laparoscopic removal of a large gastric trichobezoar. J Pediatr Surg (1998) 1.96
Phase I/II study of S-1 combined with cisplatin in patients with advanced gastric cancer. Br J Cancer (2003) 1.95
Studies on denitrification. IX. Nitrous oxide, its production and reduction to nitrogen. J Biochem (1968) 1.93
Sclerosing therapy of internal hemorrhoids with a novel sclerosing agent. Comparison with ligation and excision. Int J Colorectal Dis (2005) 1.91
Demonstration of mother-to-infant transmission of hepatitis B virus by means of polymerase chain reaction. Lancet (1989) 1.90
Microglial activation resulting from CD40-CD40L interaction after beta-amyloid stimulation. Science (1999) 1.88
Constitutive activation of NF-kappa B is essential for transformation of rat fibroblasts by the human T-cell leukemia virus type I Tax protein. EMBO J (1996) 1.85
Interleukin-6 as a new indicator of inflammatory status: detection of serum levels of interleukin-6 and C-reactive protein after surgery. Surgery (1992) 1.84
Ongoing prospective study of segmentectomy for small lung tumors. Study Group of Extended Segmentectomy for Small Lung Tumor. Ann Thorac Surg (1998) 1.83
Comparison of erythema and induration as results of tuberculin tests. Int J Tuberc Lung Dis (2005) 1.77
Mutations in SLC4A4 cause permanent isolated proximal renal tubular acidosis with ocular abnormalities. Nat Genet (1999) 1.75
OPC-41061, a highly potent human vasopressin V2-receptor antagonist: pharmacological profile and aquaretic effect by single and multiple oral dosing in rats. J Pharmacol Exp Ther (1998) 1.74
Circadian rhythms in rapidly dividing cyanobacteria. Science (1997) 1.74
Thoracoscopic esophagomyotomy. Initial experience with a new approach for the treatment of achalasia. Ann Surg (1992) 1.73
Expression of vascular endothelial growth factor (VEGF) in epithelial ovarian neoplasms: correlation with clinicopathology and patient survival, and analysis of serum VEGF levels. Br J Cancer (1997) 1.72
Surgical results for small cell lung cancer based on the new TNM staging system. Thoracic Surgery Study Group of Osaka University, Osaka, Japan. Ann Thorac Surg (2000) 1.71
HTLV-1 Tax induces expression of various immediate early serum responsive genes. Oncogene (1991) 1.71
Gains, losses, and amplifications of genomic materials in primary gastric cancers analyzed by comparative genomic hybridization. Genes Chromosomes Cancer (1999) 1.68
Questionnaires to assess urinary and anal incontinence: review and recommendations. J Urol (2007) 1.67
Detection and sequencing of measles virus from peripheral mononuclear cells from patients with inflammatory bowel disease and autism. Dig Dis Sci (2000) 1.67
Hepatic resection for hepatocellular carcinoma. Surgery (1990) 1.64
Report on the computer software contest at 38th Congress of the Japan Society of Anesthesiology. J Anesth (1991) 1.62
Development and aging of the cerebrum: assessment with proton MR spectroscopy. AJNR Am J Neuroradiol (2001) 1.62
Lack of tissue specificity of calmodulin: a rapid and high-yield purification method. FEBS Lett (1981) 1.61
Functional expression of costimulatory molecule CD86 on epithelial cells in the inflamed colonic mucosa. Gastroenterology (1999) 1.61
Antibody removal therapy used successfully at delivery of a pregnant patient with Glanzmann's thrombasthenia and multiple anti-platelet antibodies. Vox Sang (1991) 1.60
Pathology of small hepatocellular carcinoma. A proposal for a new gross classification. Cancer (1987) 1.60
Report on the computer software contest at the 39th Congress of the Lapan Society of Anesthesiology. J Anesth (1993) 1.59
Prolonged survival of hamster-to-rat liver xenografts using splenectomy and cyclosporine administration. Transplantation (1987) 1.59
Ulcerative duodenitis accompanying ulcerative colitis. J Clin Gastroenterol (2001) 1.58
Idiopathic pulmonary fibrosis. Epidemiologic approaches to occupational exposure. Am J Respir Crit Care Med (1994) 1.57
Mechanism and clinical significance of elevated CA 125 levels in the sera of pregnant women. Am J Obstet Gynecol (1989) 1.57
Anti-annexin V antibody in systemic lupus erythematosus patients with lupus anticoagulant and/or anticardiolipin antibody. Am J Hematol (1994) 1.55
Autologous serum eye drops for the treatment of severe dry eye in patients with chronic graft-versus-host disease. Bone Marrow Transplant (2003) 1.55
Molecular cloning of complementary DNA for a novel human hepatoma-derived growth factor. Its homology with high mobility group-1 protein. J Biol Chem (1994) 1.55
Synthesis of a new cell penetrating calpain inhibitor (calpeptin). Biochem Biophys Res Commun (1988) 1.54
Vascular endothelial growth factor enhances glomerular capillary repair and accelerates resolution of experimentally induced glomerulonephritis. Am J Pathol (2001) 1.54
Amplification of the TCL1 flanking region at 14q32.1 with no TCL1 gene transcription in a patient with peripheral T cell lymphoma. Leukemia (1998) 1.54
Electrolyzed-reduced water scavenges active oxygen species and protects DNA from oxidative damage. Biochem Biophys Res Commun (1997) 1.53
Topical formulations and wound healing applications of chitosan. Adv Drug Deliv Rev (2001) 1.52
A severe outbreak of haemorrhagic colitis and haemolytic uraemic syndrome associated with Escherichia coli O157:H7 in Japan. Eur J Pediatr (1994) 1.52
In situ visualization of ultraviolet-light-induced DNA damage repair in locally irradiated human fibroblasts. J Invest Dermatol (2001) 1.52
Expression and clinical significance of erb-B receptor family in hepatocellular carcinoma. Br J Cancer (2001) 1.51
Pulmonary embolism in patients with isolated soleal vein thrombosis. Angiology (1998) 1.51
Loss of genes on the long arm of chromosome 22 in human meningiomas. Mol Biol Med (1988) 1.50
Esophageal web in Plummer-Vinson syndrome. Laryngoscope (1988) 1.50
Coexistence of somatic and germ-line mutations of APC gene in desmoid tumors from patients with familial adenomatous polyposis. Cancer Res (1993) 1.49
Inactivation of aerobic and hypoxic cells from three different cell lines by accelerated (3)He-, (12)C- and (20)Ne-ion beams. Radiat Res (2000) 1.49
MicroRNA-21 induces resistance to the anti-tumour effect of interferon-α/5-fluorouracil in hepatocellular carcinoma cells. Br J Cancer (2010) 1.48
Frequent mutation of beta-catenin and APC genes in primary colorectal tumors from patients with hereditary nonpolyposis colorectal cancer. Cancer Res (1999) 1.48